Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study

Abstract Purpose The aim of this study is to compare mid-term clinical outcome of direct superior approach (DSA) and posterolateral approach (PLA) in THA. Method Seventy-eight patients who underwent THA from January 2021 to June 2021 were prospectively enrolled and randomly allocated into DSA group...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhanqi Wei, Yiming Xu, Wei Zhu, Xisheng Weng, Bin Feng
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-024-08271-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572065798946816
author Zhanqi Wei
Yiming Xu
Wei Zhu
Xisheng Weng
Bin Feng
author_facet Zhanqi Wei
Yiming Xu
Wei Zhu
Xisheng Weng
Bin Feng
author_sort Zhanqi Wei
collection DOAJ
description Abstract Purpose The aim of this study is to compare mid-term clinical outcome of direct superior approach (DSA) and posterolateral approach (PLA) in THA. Method Seventy-eight patients who underwent THA from January 2021 to June 2021 were prospectively enrolled and randomly allocated into DSA group and PLA group. The surgical duration, incision length, total blood loss, ambulation time, visual analogue scale (VAS), patient satisfaction, Harris hip score (HHS), Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score, postoperative leg length discrepancy (LLD), abduction angle, anteversion angle and complications were compared between the two groups. Results Thirty three patients were randomized to the PLA group and 32 patients allocated to the DSA group. The average follow-up period was 39.8 months in DSA group and 40.1 months in PLA group. Compared with PLA group, DSA group had longer surgical duration ([124.1 ± 11.2] min vs. [103.3 ± 20.7] min), less total blood loss ([482.4 ± 236.1] ml vs. [680.2 ± 299.4] ml), shorter incision ([8.7 ± 1.9] cm vs. [15.6 ± 1.7] cm), and earlier ambulation time ([15.8 ± 4.0] h vs. [20.5 ± 3.5] h), with statistically significant differences (P < 0.0001). Furthermore, the DSA group had significantly lower WOMAC Scores compared to the PLA group at 1-year postoperatively (P = 0.011), and had significantly lower WOMAC Function Scores and WOMAC Stiffness Scores both at 1-year postoperatively and at the last follow-up. The anteversion angle of the cup in the DSA Group was significantly smaller than the PLA Group at postoperative day (POD) 3 and the last follow-up (P = 0.006 and P = 0.010, respectively). However, there was no difference in postoperative patient satisfaction, complication, LLD or HHS between the two groups. Conclusion DSA demonstrated benefits in terms of reduced blood loss, improved pain scores, shorter incisions, and earlier ambulation. These advantages support the use of DSA for promoting early recovery and better mid-term functional outcomes. Trial registration The study protocol was registered on Chinese Clinical Trial Register (ChiCTR) with the register number ChiCTR2000041186 (registration date: 2020/12/21).
format Article
id doaj-art-4c1987f65b904100b2b5e4a31b3b23e0
institution Kabale University
issn 1471-2474
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj-art-4c1987f65b904100b2b5e4a31b3b23e02025-02-02T12:05:38ZengBMCBMC Musculoskeletal Disorders1471-24742025-01-0126111110.1186/s12891-024-08271-7Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled studyZhanqi Wei0Yiming Xu1Wei Zhu2Xisheng Weng3Bin Feng4Department of Joint Surgery, the First Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Purpose The aim of this study is to compare mid-term clinical outcome of direct superior approach (DSA) and posterolateral approach (PLA) in THA. Method Seventy-eight patients who underwent THA from January 2021 to June 2021 were prospectively enrolled and randomly allocated into DSA group and PLA group. The surgical duration, incision length, total blood loss, ambulation time, visual analogue scale (VAS), patient satisfaction, Harris hip score (HHS), Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score, postoperative leg length discrepancy (LLD), abduction angle, anteversion angle and complications were compared between the two groups. Results Thirty three patients were randomized to the PLA group and 32 patients allocated to the DSA group. The average follow-up period was 39.8 months in DSA group and 40.1 months in PLA group. Compared with PLA group, DSA group had longer surgical duration ([124.1 ± 11.2] min vs. [103.3 ± 20.7] min), less total blood loss ([482.4 ± 236.1] ml vs. [680.2 ± 299.4] ml), shorter incision ([8.7 ± 1.9] cm vs. [15.6 ± 1.7] cm), and earlier ambulation time ([15.8 ± 4.0] h vs. [20.5 ± 3.5] h), with statistically significant differences (P < 0.0001). Furthermore, the DSA group had significantly lower WOMAC Scores compared to the PLA group at 1-year postoperatively (P = 0.011), and had significantly lower WOMAC Function Scores and WOMAC Stiffness Scores both at 1-year postoperatively and at the last follow-up. The anteversion angle of the cup in the DSA Group was significantly smaller than the PLA Group at postoperative day (POD) 3 and the last follow-up (P = 0.006 and P = 0.010, respectively). However, there was no difference in postoperative patient satisfaction, complication, LLD or HHS between the two groups. Conclusion DSA demonstrated benefits in terms of reduced blood loss, improved pain scores, shorter incisions, and earlier ambulation. These advantages support the use of DSA for promoting early recovery and better mid-term functional outcomes. Trial registration The study protocol was registered on Chinese Clinical Trial Register (ChiCTR) with the register number ChiCTR2000041186 (registration date: 2020/12/21).https://doi.org/10.1186/s12891-024-08271-7Total hip arthroplastyDirect superior approachPosterolateral approachMid-term outcome
spellingShingle Zhanqi Wei
Yiming Xu
Wei Zhu
Xisheng Weng
Bin Feng
Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
BMC Musculoskeletal Disorders
Total hip arthroplasty
Direct superior approach
Posterolateral approach
Mid-term outcome
title Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
title_full Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
title_fullStr Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
title_full_unstemmed Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
title_short Direct superior approach versus posterolateral approach in mid-term clinical outcomes of total hip arthroplasty: a prospective randomized controlled study
title_sort direct superior approach versus posterolateral approach in mid term clinical outcomes of total hip arthroplasty a prospective randomized controlled study
topic Total hip arthroplasty
Direct superior approach
Posterolateral approach
Mid-term outcome
url https://doi.org/10.1186/s12891-024-08271-7
work_keys_str_mv AT zhanqiwei directsuperiorapproachversusposterolateralapproachinmidtermclinicaloutcomesoftotalhiparthroplastyaprospectiverandomizedcontrolledstudy
AT yimingxu directsuperiorapproachversusposterolateralapproachinmidtermclinicaloutcomesoftotalhiparthroplastyaprospectiverandomizedcontrolledstudy
AT weizhu directsuperiorapproachversusposterolateralapproachinmidtermclinicaloutcomesoftotalhiparthroplastyaprospectiverandomizedcontrolledstudy
AT xishengweng directsuperiorapproachversusposterolateralapproachinmidtermclinicaloutcomesoftotalhiparthroplastyaprospectiverandomizedcontrolledstudy
AT binfeng directsuperiorapproachversusposterolateralapproachinmidtermclinicaloutcomesoftotalhiparthroplastyaprospectiverandomizedcontrolledstudy